Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Illumina, Inc. (ILMN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Illumina, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1110803.
Total stock buying since 2005: $2,748,194.
Total stock sales since 2005: $1,191,574,365.
Total stock option exercises since 2005: $187,225,090.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 18,450 | $1,500,027 | 0 | $0 | 0 | $0 |
2024 | 7,330 | $996,344 | 0 | $0 | 0 | $0 |
2023 | 0 | $0 | 11,630 | $2,288,888 | 68,902 | $540,284 |
2022 | 0 | $0 | 6,787 | $2,313,640 | 38,110 | $0 |
2021 | 0 | $0 | 76,862 | $32,133,367 | 53,748 | $0 |
2020 | 0 | $0 | 153,063 | $51,235,027 | 107,230 | $0 |
2019 | 0 | $0 | 166,043 | $51,488,681 | 148,450 | $4,489,250 |
2018 | 0 | $0 | 207,105 | $59,766,035 | 152,950 | $3,491,285 |
2017 | 0 | $0 | 455,648 | $88,829,978 | 425,871 | $21,632,278 |
2016 | 0 | $0 | 304,789 | $48,921,636 | 545,401 | $8,014,616 |
2015 | 0 | $0 | 1,117,701 | $221,793,291 | 753,395 | $24,718,407 |
2014 | 0 | $0 | 1,302,250 | $215,660,563 | 1,262,640 | $37,615,935 |
2013 | 0 | $0 | 1,596,048 | $118,377,128 | 1,492,387 | $40,207,436 |
2012 | 1,217 | $47,458 | 186,591 | $9,547,988 | 206,000 | $3,823,781 |
2011 | 4,839 | $204,365 | 793,264 | $55,004,833 | 780,467 | $11,494,144 |
2010 | 0 | $0 | 1,462,467 | $65,282,978 | 1,178,143 | $16,880,360 |
2009 | 0 | $0 | 948,051 | $34,070,305 | 524,296 | $4,030,889 |
2008 | 0 | $0 | 999,177 | $62,564,210 | 426,200 | $4,917,923 |
2007 | 0 | $0 | 1,065,401 | $47,966,087 | 533,039 | $5,235,340 |
2006 | 0 | $0 | 553,233 | $17,611,673 | 28,700 | $133,162 |
2005 | 0 | $0 | 546,352 | $6,718,057 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-07-09 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Sale | 6,667 | 74.19 | 494,624 |
2013-07-09 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Option Ex | 6,667 | 28.45 | 189,676 |
2013-06-27 | Flatley Jay T (President & CEO) | Sale | 20,000 | 74.96 | 1,499,139 |
2013-06-27 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
2013-06-26 | Bouchard Michel (VP, Finance) | Sale | 4,272 | 75.08 | 320,741 |
2013-06-26 | Bouchard Michel (VP, Finance) | Option Ex | 4,272 | 37.12 | 158,589 |
2013-06-26 | Walt David R (Director) | Sale | 5,000 | 75.66 | 378,295 |
2013-06-25 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Sale | 35,000 | 71.98 | 2,519,300 |
2013-06-25 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Option Ex | 35,000 | 28.45 | 995,750 |
2013-06-17 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 68.56 | 137,120 |
2013-06-17 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
2013-06-14 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 25,959 | 68.10 | 1,767,911 |
2013-06-14 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 22,052 | 19.66 | 433,498 |
2013-06-13 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Sale | 47,667 | 66.55 | 3,172,238 |
2013-06-13 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Option Ex | 47,667 | 19.66 | 937,037 |
2013-06-13 | Flatley Jay T (President & CEO) | Sale | 20,000 | 66.49 | 1,329,720 |
2013-06-13 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
2013-06-12 | Bouchard Michel (VP, Finance) | Sale | 5,170 | 68.63 | 354,837 |
2013-06-12 | Bouchard Michel (VP, Finance) | Option Ex | 5,170 | 37.10 | 191,817 |
2013-06-12 | Walt David R (Director) | Sale | 5,000 | 67.79 | 338,965 |
2013-06-11 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 24,000 | 69.14 | 1,659,240 |
2013-06-11 | Ronaghi Mostafa (Sr VP & CTO) | Option Ex | 24,000 | 36.62 | 878,951 |
2013-06-03 | Eastham Karin (Director) | Sale | 10,000 | 70.34 | 703,379 |
2013-06-03 | Eastham Karin (Director) | Option Ex | 10,000 | 13.30 | 133,000 |
2013-05-31 | Lewis Mark L (Sr VP & General Manager) | Sale | 13,000 | 71.82 | 933,634 |
2013-05-31 | Lewis Mark L (Sr VP & General Manager) | Option Ex | 13,000 | 29.20 | 379,665 |
2013-05-30 | Posard Matthew L. (Sr VP & General Manager) | Sale | 2,836 | 70.80 | 200,788 |
2013-05-30 | Posard Matthew L. (Sr VP & General Manager) | Option Ex | 2,836 | 37.04 | 105,045 |
2013-05-29 | Bouchard Michel (VP, Finance) | Sale | 6,276 | 71.00 | 445,608 |
2013-05-29 | Bouchard Michel (VP, Finance) | Option Ex | 6,276 | 37.12 | 232,983 |
2013-05-29 | Walt David R (Director) | Sale | 5,000 | 71.16 | 355,775 |
2013-05-23 | Flatley Jay T (President & CEO) | Sale | 20,000 | 68.72 | 1,374,460 |
2013-05-23 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
2013-05-21 | Flatley Jay T (President & CEO) | Sale | 4,000 | 73.21 | 292,840 |
2013-05-20 | Stapley Marc (Sr VP & CFO) | Sale | 2,843 | 72.86 | 207,135 |
2013-05-20 | Stapley Marc (Sr VP & CFO) | Option Ex | 2,843 | 36.30 | 103,200 |
2013-05-15 | Bouchard Michel (VP, Finance) | Sale | 14,241 | 70.75 | 1,007,550 |
2013-05-15 | Bouchard Michel (VP, Finance) | Option Ex | 9,002 | 34.95 | 314,664 |
2013-05-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 70.72 | 141,440 |
2013-05-15 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
2013-05-15 | Walt David R (Director) | Sale | 5,000 | 71.07 | 355,370 |
2013-05-13 | Ronaghi Mostafa (Sr VP & CTO) | Sale | 24,000 | 69.20 | 1,660,776 |
2013-05-13 | Ronaghi Mostafa (Sr VP & CTO) | Option Ex | 24,000 | 36.62 | 878,951 |
2013-05-10 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 25,000 | 72.50 | 1,812,500 |
2013-05-10 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 25,000 | 43.37 | 1,084,250 |
2013-05-10 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Sale | 25,000 | 69.00 | 1,725,000 |
2013-05-10 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Option Ex | 25,000 | 20.04 | 501,000 |
2013-05-09 | Flatley Jay T (President & CEO) | Sale | 20,000 | 66.62 | 1,332,500 |
2013-05-09 | Flatley Jay T (President & CEO) | Option Ex | 20,000 | 10.48 | 209,700 |
2013-05-07 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Sale | 5,000 | 65.68 | 328,400 |
2013-05-07 | Orpin Tristan (Sr VP & Chief Commercial Offic) | Option Ex | 5,000 | 20.04 | 100,200 |
2013-05-01 | Walt David R (Director) | Sale | 5,000 | 64.15 | 320,750 |
2013-04-30 | Stapley Marc (Sr VP & CFO) | Sale | 15,000 | 65.00 | 975,000 |
2013-04-30 | Stapley Marc (Sr VP & CFO) | Option Ex | 15,000 | 36.30 | 544,500 |
2013-04-30 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 10,000 | 65.00 | 650,000 |
2013-04-30 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 10,000 | 43.37 | 433,700 |
2013-04-30 | Orpin Tristan (SVP & Chief Commercial Officer) | Sale | 5,000 | 65.00 | 325,000 |
2013-04-30 | Orpin Tristan (SVP & Chief Commercial Officer) | Option Ex | 5,000 | 20.04 | 100,200 |
2013-04-25 | Flatley Jay T (President & CEO) | Sale | 10,000 | 62.62 | 626,150 |
2013-04-25 | Flatley Jay T (President & CEO) | Option Ex | 10,000 | 10.48 | 104,850 |
2013-04-23 | Stapley Marc (Sr VP & CFO) | Sale | 12,710 | 60.00 | 762,600 |
2013-04-23 | Stapley Marc (Sr VP & CFO) | Option Ex | 10,710 | 36.30 | 388,772 |
2013-04-23 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Sale | 2,000 | 60.00 | 120,000 |
2013-04-23 | Naclerio Nicholas (Sr VP, Corporate & Venture Dev) | Option Ex | 2,000 | 43.37 | 86,740 |
2013-04-23 | Ronaghi Mostafa (Sr Vice President & CTO) | Sale | 59,000 | 60.00 | 3,540,000 |
2013-04-23 | Ronaghi Mostafa (Sr Vice President & CTO) | Option Ex | 59,000 | 36.62 | 2,160,757 |
2013-04-23 | Cabou Christian (Sr VP & General Counsel) | Sale | 13,937 | 60.00 | 836,220 |
2013-04-23 | Cabou Christian (Sr VP & General Counsel) | Option Ex | 13,937 | 37.04 | 516,226 |
2013-04-22 | Stapley Marc (Sr VP & CFO) | Sale | 2,133 | 55.40 | 118,163 |
2013-04-22 | Stapley Marc (Sr VP & CFO) | Option Ex | 2,133 | 36.30 | 77,427 |
2013-04-17 | Walt David R (Director) | Sale | 5,000 | 57.55 | 287,740 |
2013-04-17 | Walt David R (Director) | Option Ex | 5,000 | 1.03 | 5,175 |
2013-04-11 | Posard Matthew L. (Sr VP & General Manager) | Sale | 48,232 | 57.95 | 2,795,044 |
2013-04-11 | Posard Matthew L. (Sr VP & General Manager) | Option Ex | 48,232 | 31.12 | 1,501,172 |
2013-04-11 | Stapley Marc (Sr VP & CFO) | Sale | 710 | 58.00 | 41,180 |
2013-04-11 | Stapley Marc (Sr VP & CFO) | Option Ex | 710 | 36.30 | 25,772 |
2013-04-11 | Flatley Jay T (President & CEO) | Sale | 10,000 | 57.29 | 572,860 |
2013-04-11 | Flatley Jay T (President & CEO) | Option Ex | 10,000 | 10.48 | 104,850 |
2013-04-08 | Stapley Marc (Sr VP & CFO) | Sale | 9,175 | 55.00 | 504,625 |
2013-04-08 | Stapley Marc (Sr VP & CFO) | Option Ex | 7,500 | 36.30 | 272,250 |
2013-04-08 | Cabou Christian (Sr VP & General Counsel) | Sale | 16,500 | 55.00 | 907,500 |
2013-04-08 | Cabou Christian (Sr VP & General Counsel) | Option Ex | 16,500 | 37.04 | 611,160 |
2013-04-08 | Rastetter William H (Director) | Sale | 20,000 | 54.95 | 1,099,000 |
2013-04-08 | Rastetter William H (Director) | Option Ex | 20,000 | 1.03 | 20,700 |
2013-04-03 | Walt David R (Director) | Sale | 5,000 | 54.08 | 270,420 |
2013-04-03 | Walt David R (Director) | Option Ex | 5,000 | 1.03 | 5,175 |
2013-03-28 | Flatley Jay T (President & CEO) | Sale | 5,000 | 54.11 | 270,540 |
2013-03-28 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2013-03-20 | Stapley Marc (Sr VP & CFO) | Sale | 2,133 | 52.76 | 112,545 |
2013-03-20 | Stapley Marc (Sr VP & CFO) | Option Ex | 2,133 | 36.30 | 77,427 |
2013-03-20 | Walt David R (Director) | Sale | 5,000 | 52.78 | 263,905 |
2013-03-20 | Walt David R (Director) | Option Ex | 5,000 | 1.03 | 5,175 |
2013-03-14 | Flatley Jay T (President & CEO) | Sale | 5,000 | 52.62 | 263,075 |
2013-03-14 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2013-03-11 | Stapley Marc (Sr VP & CFO) | Sale | 4,468 | 53.71 | 239,958 |
2013-03-11 | Stapley Marc (Sr VP & CFO) | Option Ex | 4,468 | 36.30 | 162,188 |
2013-03-06 | Walt David R (Director) | Sale | 5,000 | 53.26 | 266,320 |
2013-03-06 | Walt David R (Director) | Option Ex | 5,000 | 1.03 | 5,175 |
2013-02-28 | Flatley Jay T (President & CEO) | Sale | 5,000 | 49.55 | 247,740 |
2013-02-28 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2013-02-14 | Flatley Jay T (President & CEO) | Sale | 5,000 | 49.45 | 247,250 |
2013-02-14 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2013-01-31 | Cabou Christian (Sr VP & General Counsel) | Sale | 35,000 | 50.54 | 1,768,935 |
2013-01-31 | Cabou Christian (Sr VP & General Counsel) | Option Ex | 35,000 | 13.70 | 479,500 |
2013-01-30 | Cabou Christian (Sr VP & General Counsel) | Sale | 55,500 | 50.80 | 2,819,400 |
2013-01-30 | Cabou Christian (Sr VP & General Counsel) | Option Ex | 55,500 | 26.99 | 1,498,056 |
2013-01-24 | Flatley Jay T (President & CEO) | Sale | 5,000 | 51.02 | 255,075 |
2013-01-24 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2013-01-10 | Flatley Jay T (President & CEO) | Sale | 5,000 | 52.93 | 264,650 |
2013-01-10 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2012-12-27 | Flatley Jay T (President and CEO) | Sale | 10,000 | 55.53 | 555,290 |
2012-12-27 | Flatley Jay T (President and CEO) | Option Ex | 10,000 | 10.48 | 104,850 |
2012-12-20 | Lewis Mark L (Sr VP & General Manager) | Sale | 24,500 | 56.21 | 1,377,145 |
2012-12-20 | Lewis Mark L (Sr VP & General Manager) | Option Ex | 24,500 | 37.04 | 907,480 |
2012-12-19 | Lewis Mark L (Sr VP & General Manager) | Sale | 5,000 | 51.87 | 259,360 |
2012-12-19 | Lewis Mark L (Sr VP & General Manager) | Option Ex | 5,000 | 21.37 | 106,850 |
2012-12-13 | Flatley Jay T (President & CEO) | Sale | 5,000 | 52.74 | 263,720 |
2012-12-13 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2012-11-23 | Flatley Jay T (President & CEO) | Sale | 5,000 | 53.31 | 266,575 |
2012-11-23 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 10.48 | 52,425 |
2012-11-19 | Lewis Mark L (Sr VP & GM Molecular Biology) | Sale | 5,000 | 50.00 | 250,000 |
2012-11-19 | Lewis Mark L (Sr VP & GM Molecular Biology) | Option Ex | 5,000 | 21.37 | 106,850 |
2012-11-08 | Flatley Jay T (President & CEO) | Sale | 5,000 | 47.99 | 239,935 |
2012-11-08 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 4.30 | 21,500 |
2012-10-25 | Flatley Jay T (President & CEO) | Sale | 5,000 | 46.78 | 233,900 |
2012-10-25 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 4.30 | 21,500 |
2012-10-11 | Flatley Jay T (President & CEO) | Sale | 5,000 | 51.58 | 257,875 |
2012-10-11 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 4.30 | 21,500 |
2012-10-09 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 10,000 | 51.70 | 516,960 |
2012-10-09 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 10,000 | 26.26 | 262,620 |
2012-09-27 | Flatley Jay T (President & CEO) | Sale | 5,000 | 46.87 | 234,340 |
2012-09-27 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 4.30 | 21,500 |
2012-09-14 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 30,000 | 48.00 | 1,440,000 |
2012-09-14 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 30,000 | 20.04 | 601,200 |
2012-09-13 | Flatley Jay T (President & CEO) | Sale | 5,000 | 45.00 | 225,000 |
2012-09-13 | Flatley Jay T (President & CEO) | Option Ex | 5,000 | 4.30 | 21,500 |
2012-06-01 | Eastham Karin (Director) | Sale | 10,000 | 41.90 | 419,000 |
2012-06-01 | Eastham Karin (Director) | Option Ex | 10,000 | 9.76 | 97,620 |
2012-05-11 | Walt David R (Director) | Option Ex | 20,000 | 3.25 | 65,000 |
2012-04-18 | Bowman A Blaine (Director) | Buy | 408 | 43.87 | 17,900 |
2012-04-11 | Henry Christian O (Sr VP, General Manager Genomic) | Sale | 10,000 | 52.51 | 525,070 |
2012-04-11 | Henry Christian O (Sr VP, General Manager Genomic) | Option Ex | 10,000 | 26.26 | 262,620 |
2012-03-07 | Henry Christian O (Sr VP & GM Genomic Solutions) | Sale | 10,000 | 50.53 | 505,310 |
2012-03-07 | Henry Christian O (Sr VP & GM Genomic Solutions) | Option Ex | 10,000 | 26.26 | 262,620 |
2012-02-14 | Henry Christian O (Sr VP, GM Life Science) | Sale | 10,000 | 53.78 | 537,790 |
2012-02-14 | Henry Christian O (Sr VP, GM Life Science) | Option Ex | 10,000 | 26.26 | 262,620 |
2012-01-27 | Bowman A Blaine (Director) | Sale | 321 | 52.13 | 16,733 |
2012-01-26 | Bowman A Blaine (Director) | Sale | 270 | 52.54 | 14,185 |
2012-01-25 | Henry Christian O (Sr VP and GM) | Sale | 26,500 | 53.20 | 1,409,800 |
2012-01-25 | Henry Christian O (Sr VP and GM) | Option Ex | 26,500 | 21.55 | 571,101 |
Insider trading activities including stock purchases, stock sales, and option exercises of ILMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Illumina, Inc. (symbol ILMN, CIK number 1110803) see the Securities and Exchange Commission (SEC) website.